OBN and EBD Group Announce BioTrinity's Emergence as the Largest Biotech Partnering Event in the UK

OXFORD, England and ZURICH, Switzerland, April 15, 2011 /PRNewswire/ --

- partneringONE(R) Helps Fuel BioTrinity's Growth and Partnering Productivity

OBN and EBD Group today announced the results of the fifth annual BioTrinity Biopartnering and Investment Conference. Held April 12-14 at the Newbury Racecourse, in Newbury, UK, BioTrinity has grown to become the largest event of the UK bioindustry with 750 delegates, and has now been Europe's fastest growing early-stage investment and partnering event for three years running.

In the past three editions, BioTrinity has more than doubled in size, from 350 to 750 delegates. The 2011 conference welcomed over 450 companies from 19 countries across Europe, Asia and North America. The 2011 event also featured 75 investment firms that specialize in funding emerging biotechnology companies. partneringONE(R) has been the partnering engine for BioTrinity over the past five years. During that time, partnering at the event has grown from 500 one-to-one meetings to 1,700.

"In each of its five years, BioTrinity has achieved that 'magic mix' of R&D companies, investors and global pharma. Using partneringONE, we are able to ensure that our mix of attendees is able to identify new business opportunities and investment, and share sector knowledge," said Jon Rees, CEO, OBN. "We look forward to working with EBD Group in 2012 and beyond to continue to provide EBD Group's gold standard partnering services to BioTrinity participants."

"We are gratified that partneringONE is helping to fuel BioTrinity's fast growth, creating a strong UK-based event that attracts a growing international audience," said Carola Schropp, President, EBD Group. "At BioTrinity, partneringONE is being used by delegates and investors alike to find and create powerful relationships to drive the industry forward. It is not only at EBD Group events that partneringONE is contributing to the growth of the industry."

"The key to a conference's sustained growth is providing attendees with a high, measurable return on investment. partneringONE helps achieve this by facilitating meaningful interactions among delegates; interactions that lead to profitable new business opportunities," Schropp added.

BioTrinity 2011 featured a showcase of the best of the UK's emerging and clinical stage companies. Big pharma and their corporate venturers participating in 2011 included Abbott, AstraZeneca, Baxter, Boehringer, Fosun Pharma, GSK, Lilly, Lundbeckfund, Merck, Merck Serono, Novartis, Novo A/S, Pfizer, sanofi-aventis, Shire, Smith & Nephew, Takeda, and Teva.

partneringONE is the leading conference partnering service enabling delegates to efficiently meet and do business. Combining the industry's most advanced networking software with best practice implementation, partneringONE turns any conference into a world-class partnering event. As the partnering engine for over twenty-five clients around the world including six new events in the past twelve months, partneringONE utilizes the most advanced and intuitive software for generating connections that matter.

About EBD Group

EBD Group is the leading partnering firm for the global life science industry. Since 1993, biotech, pharma and medical device companies have leveraged EBD Group's partnering conferences, technology and services to identify business opportunities and develop strategic relationships essential to their success.

EBD Group's conferences are run with the support of leading corporations and international trade associations, and include:

- BIO-Europe(R) and BIO-Europe Spring(R), Europe's largest life science partnering conferences, supported by the Biotechnology Industry Organization (BIO)

- BioPharm America(TM), the fastest growing partnering event in North America

- EuroMedtech(TM), EBD Group's partnering event for the innovative medical technology industry

- BioEquity Europe, the investor conference co-organized with BioCentury Publications and BIO

- ChinaBio(R) Partnering Forum, the first dedicated biotech/pharma partnering conference in China, co-produced with ChinaBio(R) LLC

- Biotech Showcase(TM), a unique forum in San Francisco for presenting to investors and business development executives, co-produced with Demy-Colton Life Science Advisors

EBD Group's sophisticated web-based partnering service, partneringONE(R), is used as the partnering engine at numerous third-party events around the world. Outside of the conference format, EBD Group's consultants provide hands-on assistance for firms seeking to in- or out-license products and technologies. EBD Group has offices in the USA and Europe. For more information visit http://www.ebdgroup.com

About OBN

OBN is a not-for-profit business network which provides comprehensive support for its member biotech and medtech companies in the Oxford and South-East England biocluster and the rest of the UK. Our activities can be summarised as networking, partnering, group purchasing, advice and information dissemination. Through its delivery of Europe's fastest growing biopartnering and investment conference, BioTrinity, OBN generates more R&D-company-to-investor interactions than anyone else in Europe. OBN is sponsored by Shire, as Corporate Patron, and Corporate Sponsors MEPC, Manches LLP, James Cowper, Red Moon Executive Search, PiR Interims, SRG, FOCUS Insurance, World Courier and Citigate Dewe Rogerson as well as by its extensive membership of R&D companies and other companies across the entire life sciences industry ecosystem. OBN counts nearly 200 companies amongst its membership, which is growing about 45% per year.

    Contacts

    OBN

    Jon Rees
    +44-7795-233-883
    [email protected]

    EBD Group

    Constantine Theodoropulos
    EBD Group
    +1-617-401-3116
    [email protected]

    Citigate Dewe Rogerson
    Nina Enegren
    +44-20-7638-9571
    [email protected]

SOURCE OBN and EBD Group